Kitti Szabó

Syndecan‐4 influences mammalian myoblast proliferation by modulating myostatin signalling and G1/S transition

L. Puskás, F. Deák, T. Kocsis, 2018, FEBS letters.

Species specificity profiling of rat and human organic cation/carnitine transporter Slc22a5/SLC22A5 (Octn2/OCTN2).

J. Zolnerciks, Z. Nagy, É. Molnár, 2017, Drug metabolism and pharmacokinetics.

Myostatin propeptide mutation of the hypermuscular Compact mice decreases the formation of myostatin and improves insulin sensitivity.

F. Deák, L. Mendler, H. Reinauer, 2017, American journal of physiology. Endocrinology and metabolism.

Syndecan-4 Modulates Cell Polarity and Migration by Influencing Centrosome Positioning and Intracellular Calcium Distribution

P. Horváth, M. Erdélyi, L. Homolya, 2020, Neuromuscular Disorders.

Indoleamine 2,3-Dioxygenase Cannot Inhibit Chlamydia trachomatis Growth in HL-60 Human Neutrophil Granulocytes

D. Virok, T. Janáky, S. Póliska, 2021, Frontiers in Immunology.

Statins alter the hepatobiliary transport of unconjugated and conjugated bilirubin in sandwich-cultured rat hepatocytes.

Emese Kis, Katalin Jemnitz, Zsuzsa Veres, 2014, Toxicology in vitro : an international journal published in association with BIBRA.

Unravelling the Effects of Syndecan-4 Knockdown on Skeletal Muscle Functions

L. Csernoch, Zoltán Márton Köhler, Mónika Sztretye, 2023, International journal of molecular sciences.

Syndecan-4 affects myogenesis via Rac1-mediated actin remodeling and exhibits copy-number amplification and increased expression in human rhabdomyosarcoma tumors

M. Erdélyi, Ning Liu, Lin Xu, 2022, Cellular and Molecular Life Sciences.

Amyloid-like Fibril Formation by Trypsin in Aqueous Ethanol. Inhibition of Fibrillation by PEG.

M. Kotormán, A. Borics, L. Fülöp, 2015, Protein and peptide letters.